Primary Well-Differentiated Neuroendocrine Tumor of the Kidney

Main Article Content

Vishnu Prasad
Charakkulam Vijay Sreelakshmi
K Ravi Chandran
Shashank Agrawal
Ginil Kumar Pooleri
Amrita Sao

Keywords

Neuroendocrine tumor, Radical nephrectomy, Immunohistochemistry

Abstract

Primary neuroendocrine tumors (NET) of the kidney are rare. They present with varied symptoms, making their diagnosis difficult clinically as well as pathologically. We present to you the case of a renal NET, which presented in a young female patient. A 48-year-old female patient came with an incidentally detected right renal mass during the evaluation of a nonspecific gynecological problem. She underwent contrast-enhanced computed tomography (CT) of the abdomen, which showed a 57*45*34 mm mass with enlarged retrocaval and aortocaval nodes (25*12 mm). Renal cell carcinoma was suspected as per the CT findings, and metastatic workup in the form of FDG PET CT was done in view of the unusually enlarged nodes. She underwent robot-assisted radical nephrectomy along with lymph node dissection. Surgery was uneventful, and she recovered well in the postoperative period. In the final pathology, there was confusion regarding the diagnosis, and further immunohistochemistry (IHC) was recommended by the pathologist. IHC showed synaptophysin positive, chromogranin negative, CD56 focally positive with Ki-67 of 2–3%, which was suggestive of low-grade NET of the kidney. Lymph nodes were negative. She was kept on follow-up and a Ga 68-DOTANOC scan at 3 months showed no evidence of disease. Diagnosis and management of NET of the kidney still remains a debatable and controversial topic in view of its rarity. High index of suspicion needs to be observed in patients presenting with carcinoid syndrome and a renal mass. Nuclear scans like PET scan and DOTANOC scan can accurately stage the disease. Management includes partial or radical nephrectomy depending on the tumor characteristics. Further studies are required to optimize the treatment protocols for these patients.

Abstract 442 | PDF Downloads 876 HTML Downloads 54 XML Downloads 17

References

1. Lane B, Jour G, Zhou M. Renal neuroendocrine tumors. Indian J f Urol. 2009 Jul 1;25(2):155–60. 10.4103/0970-1591.52905

2. Nguyen AH, O’Leary MP, de Andrade JP, Ituarte PHG, Kessler J, Li D, et al. Natural history of renal neuroendocrine neoplasms: A NET by any other name? Front Endocrinol (Lausanne). 2021 Feb 5;11:624251. 10.3389/fendo.2020.624251

3. Chen Y, Shu Y, He L, Wu K. Primary renal carcinoid tumors: Three case reports. Medicine. 2021 Feb 26;100(8):e24714. 10.1097/MD.0000000000024714

4. Tal R, Lask DM, Livne PM. Metastatic renal carcinoid: Case report and review of the literature. Urology. 2003 Apr 1;61(4):838. 10.1016/S0090-4295(02)02560-8

5. Krishnan B, Truong LD, Saleh G, Sirbasku DM, Slawin KM. Horseshoe kidney is associated with an increased relative risk of primary renal carcinoid tumor. J Urol. 1997;157(6):2059–66. 10.1016/S0022-5347(01)64674-3

6. Jiang H, Zhang H. Clinical and pathological features of primary renal well-differentiated neuroendocrine tumor. Onco Targets Ther. 2022 May; 15:587–96. 10.2147/OTT.S364545

7. Armah HB, Parwani AV. Primary carcinoid tumor arising within mature teratoma of the kidney: Report of a rare entity and review of the literature. Diagn Pathol. 2007; 2(1)15–15. 10.1186/1746-1596-2-15

8. Romero FR, Rais-Bahrami S, Permpongkosol S, Fine SW, Kohanim S, Jarrett TW. Primary carcinoid tumors of the kidney. J Urol. 2006;176:2359–66. 10.1016/j.juro.2006.07.129

9. Chu PG, Arber DA, Weiss LM. Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms: An immunohistochemical study of 447 cases. Am J Clin Pathol. 2003 Jul 1;120(1):64–70. 10.1309/48KC17WAU69BTBXQ

10. Kaufmann O, Georgi T, Dietel M. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on, paraffin sections. Human Pathol. 1997 Dec 1; 28(12)1373–8. 10.1016/S0046-8177(97)90226-4.

11. Chu P, Arber DA. Anatomic pathology / CD10 In nonhematopoietic neoplasms paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol. 2000;113(3):373–82. 10.1309/8VAV-J2FU-8CU9-EK18

12. Hansel DE, Epstein JI, Berbescu E, Fine S, Young RH, Cheville J. Renal carcinoid tumor: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2007;31:1539–44. 10.1097/PAS.0b013e318042d596

13. Nadler A, Cukier M, Rowsell C, Kamali S, Feinberg Y, Singh S, et al. Ki-67 is a reliable pathological grading marker for neuroendocrine tumors. Virchows Archiv. 2013 May;462(5):501–5. 10.1007/s00428-013-1410-8

14. Squires MH, Volkan Adsay N, Schuster DM, Russell MC, Cardona K, Delman KA, et al. Octreoscan versus FDG-PET for neuroendocrine tumor staging: a biological approach. Ann Surg Oncol. 2015 Jul 8;22(7):2295–301. 10.1245/s10434-015-4471-x

15. Kjaer A, Knigge U. Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors. Scand J Gastroenterol. 2015 Jun 1;50(6):740–7. 10.3109/00365521.2015.1033454

16. Zukotynski K, Lewis A, O’Regan K, Jacene H, Sakellis C, Krajewski K, et al. PET/CT and renal pathology: A blind spot for radiologists? Part 1, primary pathology. Am JRoentgenol. 2012;119(2):W163–7. 10.2214/AJR.11.7790

17. Rosenberg JE, Albersheim JA, Sathianathen NJ, Murugan P, Weight CJ. Five new cases of primary renal carcinoid tumor: Case reports and literature review. Pathol Oncol Res. 2020 Jan 1;26(1):341–6. 10.1007/s12253-018-0481-x

18. Deng W, Li J, Liu X, Chen L, Liu W, Zhou X, et al. Robot-assisted versus laparoscopic partial nephrectomy for anatomically complex T1b renal tumors with a RENAL nephrometry score ≥7: A propensity score-based analysis. Cancer Med. 2020 Jan 1;9(2):586–94. 10.1002/cam4.2749

19. Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: Experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun 1;7(3):449–61. 10.21037/jgo.2016.01.06

20. Maeda S, Itou H, Hasegawa T, Abe K, Katou N, Ikemoto I, et al. A case of primary renal carcinoid tumor. Acta Urol Japonica. 2000;46:715–17.

21. Teegavarapu PS, Rao P, Matrana M, Cauley DH, Wood CG, Tannir NM. Neuroendocrine tumors of the kidney: A single institution experience. Clin GU Cancer. 2014;12:422. 10.1016/j.clgc.2014.06.008